David A. Bench
Director/Board Member at Enzo Life Sciences (ELS) AG
Network origin in David A. Bench first degree
Entity | Entity type | Industry | |
---|---|---|---|
Enzo Life Sciences (ELS) AG
Enzo Life Sciences (ELS) AG Miscellaneous Commercial ServicesCommercial Services Part of Enzo Biochem, Inc., Enzo Life Sciences (ELS) AG is a Swiss company that offers thousands of antibodies against peptides, whole or partial proteins, and modified peptides or proteins. Enzo Life Sciences is based in Lausen, Switzerland and offers a Worry-free Antibody Trial Program, expert technical support, and worldwide distributors. The company provides reagents to ensure that vaccines are first-to-market and cost-effective.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to David A. Bench via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ENZO BIOCHEM, INC. | Biotechnology | Chief Executive Officer | |
SMU-Cox School of Business | College/University | Masters Business Admin | |
North Dakota State University | College/University | Undergraduate Degree | |
EUROIMMUN Medizinische Labordiagnostika AG
EUROIMMUN Medizinische Labordiagnostika AG Medical SpecialtiesHealth Technology EUROIMMUN Medizinische Labordiagnostika AG is a holding company, which engages in the development and production of test systems and automation solutions for the laboratory diagnosis of autoimmune and infectious diseases, allergies, and gene analyses. The company was founded by Winfried Stöcker in September 1987 and is headquartered in Luebeck, Germany. | Medical Specialties | Corporate Officer/Principal | |
Enzo Clinical Labs, Inc.
Enzo Clinical Labs, Inc. Medical/Nursing ServicesHealth Services Part of Enzo Biochem, Inc., Enzo Clinical Labs, Inc. is a clinical laboratory. The company is based in Farmingdale, NY. The CEO of the company is Hamid Erfanian. Enzo Clinical Labs was acquired by Laboratory Corp. of America Holdings from Enzo Biochem, Inc. on July 24, 2023 for $113.25 million. | Medical/Nursing Services | Chief Executive Officer |
Statistics
International
United States | 5 |
Germany | 2 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Operational
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Most connected contacts
Insiders | |
---|---|
Hamid Erfanian | 6 |
- Stock Market
- Insiders
- David A. Bench
- Company connections